D-0476-2017 Class II Terminated

Recalled by Actavis Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
February 22, 2017
Initiation Date
January 30, 2017
Termination Date
March 13, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
499320 units

Product Description

Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4

Reason for Recall

Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.

Distribution Pattern

Nationwide in US

Code Information

Lot #: 3134201, 3134202, Exp. 06/30/17; 3134319, Exp. 05/31/17; 3135246, Exp. 07/31/17; 3135247, 3136781, Exp. 08/31/17; 3136782, Exp. 09/30/17; 3136903, 3136904, Exp.10/31/17; 3138250, Exp. 07/31/17; 3138968, Exp. 08/31/17; 3140000, Exp. 09/30/17